TABLE 5.

ASSOCIATION BETWEEN RESPIRATORY SYMPTOMS AND SPECIFIC IgE AND IgG SENSITIZATION AND EXPOSURE

	PR (95% CI)
Symptoms
Asthmalike symptoms	1.2 (1.01.5)*
COPD-like symptoms	1.3 (1.0–1.7)*
Work-related chest tightness	2.0 (1.0–3.9)*
Work-related rhinitis	1.3 (0.9–1.7)
Work-related conjunctivitis	1.5 (1.0–2.1)*
Specific IgE
HDI–ImmunoCAP	2.2 (0.6–8.2)
HDIL–HSA	1.4 (0.7–3.0)†
HDIV–HSA	0.6 (0.1–3.9)‡
N3300–HSA	1.8 (0.5–7.2) ‡
N100–HSA	3.0 (1.1–8.4)*§
Specific IgG
HDI–ImmunoCAP	1.2 (0.71.9)
HDIL–HSA	1.2 (1.1–1.4)*
HDIV–HSA	2.2 (1.5–3.4)*
N3300–HSA	1.6 (1.2–2.2)*
N100–HSA	2.0 (1.5–2.6)*

Definition of abbreviations: COPD = chronic obstructive pulmonary disease; HDI = hexamethylene diisocyanate; HDI_L–HSA = HDI–HSA liquid phase; HDI_V–HSA = HDI–HSA vapor phase; HSA = human serum albumin.

Shown are prevalence ratios (95% CI) for an interquartile range increase in exposure adjusted for age, sex, smoking, and atopy.

^*P ⩽ 0.05.

^†Adjusted for age, smoking, and atopy.

^‡Adjusted for age, smoking, and sex.

^§Adjusted for age, sex, and atopy.